Expiration date: 02/2025

Act:

antipsychotic

Composition:

Olanzapine

Indications:

Schizophrenia, psychotic disorder with marked productivity (including delusions, hallucinations, atomatizmy) and / or negative (emotional flatness, reduced social activity, impoverishment of speech)

secondary affective disorders in schizophrenia. Acute manic or mixed episodes in bipolar disorder with / without psychotic symptoms and with / without rapid phase shifts.